Our Products
Our Life Science Platform
Our platform modules facilitate in speeding up ai-driven drug discovery, more reliably and unbiased.
Meta-D3
Meta-D3, an AI platform, streamlines drug discovery, integrating target identification, molecule design, antibody engineering, asset optimization, and clinical trial prediction for pharma.
Asset42
Asset42, an AI-driven platform, revitalizes underutilized pharmaceutical assets using data intelligence to uncover high-potential investments and accelerate pipeline development.
Ontosight
Leverage AI to analyze information from the largest life sciences data ocean using our self-learning ontology for continuous, real-time insights.
ADMETronAI
ADMETronAI enables fast, accurate prediction of Absorption, Distribution, Metabolism, Excretion, and Toxicity ADMET/Tox properties directly from SMILES input—empowering discovery teams to make informed decisions earlier in the drug development pipeline.
Our RWD-Exchange
Partex RWD
Our AI and Blockchain technologies aim at empowering patients to create value with their own data. To achieve this goal, we created an ecosystem comprising all potential stakeholders (i.e. CROs, BioTech, Patients) in the entire drug discovery process that will/can benefit.
Partex wins Horizon Interactive Gold Award for Curia App
Read More